Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis.
The endothelial glycocalyx (EG) is essential for proper function of the endothelium and for vascular integrity, but its role in premature atherogenesis in rheumatoid arthritis (RA) has not been studied yet. EG impairment can play a role in pathogenesis of vascular disease, and one of its characteris...
Guardado en:
Autores principales: | Gia Deyab, Trine Marita Reine, Tram Thu Vuong, Trond Jenssen, Gunnbjørg Hjeltnes, Stefan Agewall, Knut Mikkelsen, Øystein Førre, Morten Wang Fagerland, Svein Olav Kolset, Ivana Hollan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4f73757932ab476da0063beea41a4747 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis.
por: Thao H P Nguyen, et al.
Publicado: (2021) -
Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
por: Anne Mirjam Kerola, et al.
Publicado: (2021) -
Bacteria in the adventitia of cardiovascular disease patients with and without rheumatoid arthritis.
por: Samuel A Curran, et al.
Publicado: (2014) -
In vitro evaluation of disease-modifying antirheumatic drugs against rheumatoid arthritis associated pathogens of the oral microflora
por: Stefan Winkler, et al.
Publicado: (2021) -
The Effects of Syndecan on Osteoblastic Cell Adhesion Onto Nano-Zirconia Surface
por: Sun L, et al.
Publicado: (2020)